These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8765268)

  • 1. Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2.
    Lee S; Bennett PR; Overton T; Warwick R; Wu X; Redman CM
    Am J Obstet Gynecol; 1996 Aug; 175(2):455-9. PubMed ID: 8765268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers.
    Hessner MJ; McFarland JG; Endean DJ
    Transfusion; 1996 Jun; 36(6):495-9. PubMed ID: 8669079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies.
    Spence WC; Maddalena A; Demers DB; Bick DP
    J Reprod Med; 1997 Jun; 42(6):353-7. PubMed ID: 9219123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
    Poole J; Warke N; Hustinx H; Taleghani BM; Martin P; Finning K; Crew VK; Green C; Bromilow I; Daniels G
    Transfusion; 2006 Nov; 46(11):1879-85. PubMed ID: 17076841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Sequencing for Antenatal Prediction of KEL1 Blood Group Status.
    Rieneck K; Clausen FB; Dziegiel MH
    Methods Mol Biol; 2015; 1310():115-21. PubMed ID: 26024630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel KEL*1,3 allele with weak Kell antigen expression confirming the cis-modifier effect of KEL3.
    Körmöczi GF; Scharberg EA; Gassner C
    Transfusion; 2009 Apr; 49(4):733-9. PubMed ID: 19347978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells.
    Smith NH; Henry KL; Cadwell CM; Bennett A; Hendrickson JE; Frame T; Zimring JC
    Transfusion; 2012 Dec; 52(12):2620-30. PubMed ID: 22494154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point mutations characterize KEL10, the KEL3, KEL4, and KEL21 alleles, and the KEL17 and KEL11 alleles.
    Lee S; Wu X; Son S; Naime D; Reid M; Okubo Y; Sistonen P; Redman C
    Transfusion; 1996 Jun; 36(6):490-4. PubMed ID: 8669078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Easy Multiplex PCR-SSP Assay for the Genotyping of KEL1 and KEL2 in Multi-transfused Patients.
    Zarghamian P; Pourshadlou M; Mousavi Hosseini K; Sarem F; Shahabi M
    Indian J Hematol Blood Transfus; 2021 Jul; 37(3):489-491. PubMed ID: 34267472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell-free fetal DNA in maternal plasma.
    Rieneck K; Bak M; Jønson L; Clausen FB; Krog GR; Tommerup N; Nielsen LK; Hedegaard M; Dziegiel MH
    Transfusion; 2013 Nov; 53(11 Suppl 2):2892-8. PubMed ID: 23550721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New KEL*01M and KEL*02M alleles: structural modeling to assess the impact of amino acid changes.
    Silvy M; Callebaut I; Filosa L; Granier T; Chiaroni J; Bailly P
    Transfusion; 2016 May; 56(5):1223-9. PubMed ID: 26996808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.
    Li Y; Finning K; Daniels G; Hahn S; Zhong X; Holzgreve W
    Prenat Diagn; 2008 Mar; 28(3):203-8. PubMed ID: 18241084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic diversity of KELnull and KELel: a nationwide Austrian survey.
    Körmöczi GF; Wagner T; Jungbauer C; Vadon M; Ahrens N; Moll W; Mühlbacher A; Ozgül-Gülce S; Kleinrath T; Kilga-Nogler S; Schönitzer D; Gassner C
    Transfusion; 2007 Apr; 47(4):703-14. PubMed ID: 17381630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Another example of a KEL1 variant red cell phenotype due to a threonine to serine change at position 193 of Kell glycoprotein.
    Lee-Stroka H; Slezak SL; Adams S; Martin J; Robbins FM; Caruccio L; Byrne KM; Stroncek DF
    Transfusion; 2008 May; 48(5):925-9. PubMed ID: 18248571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Potential of Effective Noninvasive Exclusion of KEL1-Positive Fetuses in KEL1-Negative Pregnant Women.
    Böhmova J; Vodicka R; Lubusky M; Holuskova I; Studnickova M; Kratochvilova R; Krejcirikova E; Janikova M; Durdová V; Dolezalová T; Filipová H; Dusek L; Dhaifalah I; Vomackova K; Kacerovsky M; Prochazka M; Vrtel R
    Fetal Diagn Ther; 2016; 40(1):48-53. PubMed ID: 26492079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KEL*02 alleles with alterations in and around exon 8 in individuals with apparent KEL:1,-2 phenotypes.
    Wester ES; Steffensen R; Ligthart PC; Vad J; de Haas M; Storry JR; Olsson ML
    Vox Sang; 2010 Aug; 99(2):150-7. PubMed ID: 20384970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping for Kidd, Kell, Duffy, Scianna, and RHCE blood group antigens polymorphisms in Jiangsu Chinese Han.
    Liu Z; Zeng R; Chen Q; Li M; Shi GY; Wei P; Huang CY; Tang RC; Sun J; Zhang XG
    Chin Med J (Engl); 2012 Mar; 125(6):1076-81. PubMed ID: 22613534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prenatal typing of Rh- and Kell- blood group system antigens].
    Faas BH; Maaskant-van Wijk PA; Beuling EA; Overbeeke MA; van der Schoot CE; Christiaens GC
    Ned Tijdschr Geneeskd; 1999 Sep; 143(36):1804-7. PubMed ID: 10526582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens.
    Yu LC; Twu YC; Chang CY; Lin M
    J Biol Chem; 2001 Mar; 276(13):10247-52. PubMed ID: 11134029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An easy and efficient strategy for KEL genotyping in a multiethnic population.
    Arnoni CP; Muniz JG; de Paula TA; Person RD; Gazito D; Baleotti W; Barreto JA; Castilho L; Latini FR
    Rev Bras Hematol Hemoter; 2013; 35(2):99-102. PubMed ID: 23741186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.